News

Inovio Presents Progression Free Survival & PSA Doubling Time Improvements in Prostate Cancer Patients Treated with INO-5150

Another exciting milestone for DF/Net client, Inovio Pharmaceuticals, Inc. Inovio Presents Progression Free Survival & PSA Doubling…

Immunotherapy targeting HPV 16/18 generates potent immune responses in HPV-Associated Head and Neck Cancer

More exciting news from DF/Net client, Inovio Pharmaceuticals, Inc. Major Cancer Journal Highlights Data From An Inovio-Sponsored Trial In Which A Patient Achieved Full Remission After Dosing With DNA Immunotherapy and Checkpoint…

HPTN 074 Demonstrates Significant Benefits Among People Living with HIV Who Inject Drugs

More terrific, breaking news from our friends at the HIV Prevention Trials Network. We've had the pleasure of providing data management support for the HPTN 074 trial since January 2015. Congratulations to…

FDA Approves the First One-Year Contraceptive Fully under a Woman’s Control

Fantastic news from longtime DF/Net customer, Population Council. "The first and only contraceptive to provide a full year of protection against unintended pregnancy while fully under a woman’s control is approved by FDA".…

DF/Net Research Launches DFdiscover 2018

DFdiscover 2018, the most feature-rich release in the software’s history, will change the way our users interact with clinical trial data. SEATTLE, WA, May 31, 2018 – DF/Net Research Inc., a leading data management…

Inovio Pharmaceuticals Demonstrates PSA Stabilizing Effect of INO-5150 Immunotherapy in Phase 1b Study for Prostate Cancer

What motivates us? Hearing about our clients' positive results! "Inovio Pharmaceuticals Demonstrates PSA Stabilizing Effect of…

iPrEx OLE Study: Gladstone Institute

After the success of iPrEx, DF/Net continued working with the Gladstone Institute, providing the data management for iPrEx OLE. iPrEx OLE (Open Label Extension) is a continuation of the iPrEx study designed…

International Partnership for Microbicides (IPM)

DF/Net has been working with IPM since 2007 on over sixteen microbicide studies, including the current large-scale IPM 027 clinical trial, The Ring Study. The Ring Study is designed to determine whether…

DF/Net Expands its Presence in Global Health Clinical Research

DF/Net is pleased to announce our selection as one of five preferred providers to the Global Health Clinical Consortium (GHCC). DF/Net provides clinical trial data management software and services for biotech, pharmaceutical,…